118 related articles for article (PubMed ID: 28334946)
1. Mutations affecting the transmembrane domain of the LDL receptor: impact of charged residues on the membrane insertion.
Strøm TB; Laerdahl JK; Leren TP
Hum Mol Genet; 2017 May; 26(9):1634-1642. PubMed ID: 28334946
[TBL] [Abstract][Full Text] [Related]
2. Mutation p.L799R in the LDLR, which affects the transmembrane domain of the LDLR, prevents membrane insertion and causes secretion of the mutant LDLR.
Strøm TB; Laerdahl JK; Leren TP
Hum Mol Genet; 2015 Oct; 24(20):5836-44. PubMed ID: 26220972
[TBL] [Abstract][Full Text] [Related]
3. Mutation G805R in the transmembrane domain of the LDL receptor gene causes familial hypercholesterolemia by inducing ectodomain cleavage of the LDL receptor in the endoplasmic reticulum.
Strøm TB; Tveten K; Laerdahl JK; Leren TP
FEBS Open Bio; 2014; 4():321-7. PubMed ID: 24918045
[TBL] [Abstract][Full Text] [Related]
4. PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment.
Tveten K; Str M TB; Berge KE; Leren TP
J Lipid Res; 2013 Jun; 54(6):1560-1566. PubMed ID: 23509406
[TBL] [Abstract][Full Text] [Related]
5. A novel indel variant in LDLR responsible for familial hypercholesterolemia in a Chinese family.
Shu H; Chi J; Li J; Zhang W; Lv W; Wang J; Deng Y; Hou X; Wang Y
PLoS One; 2017; 12(12):e0189316. PubMed ID: 29228028
[TBL] [Abstract][Full Text] [Related]
6. Endoplasmic reticulum quality control of LDLR variants associated with familial hypercholesterolemia.
Kizhakkedath P; John A; Al-Sawafi BK; Al-Gazali L; Ali BR
FEBS Open Bio; 2019 Nov; 9(11):1994-2005. PubMed ID: 31587492
[TBL] [Abstract][Full Text] [Related]
7. PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulum.
Strøm TB; Tveten K; Leren TP
Biochem J; 2014 Jan; 457(1):99-105. PubMed ID: 24144304
[TBL] [Abstract][Full Text] [Related]
8. Characterization of residues in the cytoplasmic domain of the LDL receptor required for exit from the endoplasmic reticulum.
Strøm TB; Tveten K; Holla ØL; Cameron J; Berge KE; Leren TP
Biochem Biophys Res Commun; 2011 Dec; 415(4):642-5. PubMed ID: 22079632
[TBL] [Abstract][Full Text] [Related]
9. Trafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal Domain.
Poirier S; Hamouda HA; Villeneuve L; Demers A; Mayer G
PLoS One; 2016; 11(6):e0157230. PubMed ID: 27280970
[TBL] [Abstract][Full Text] [Related]
10. Familial hypercholesterolemia class II low-density lipoprotein receptor response to statin treatment.
Omer L; Hindi L; Militello G; Stivers KB; Tien KC; Boyd NL
Dis Model Mech; 2020 Apr; 13(4):. PubMed ID: 32005714
[TBL] [Abstract][Full Text] [Related]
11. Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B.
Gillian-Daniel DL; Bates PW; Tebon A; Attie AD
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4337-42. PubMed ID: 11904390
[TBL] [Abstract][Full Text] [Related]
12. Activity-associated effect of LDL receptor missense variants located in the cysteine-rich repeats.
Etxebarria A; Benito-Vicente A; Stef M; Ostolaza H; Palacios L; Martin C
Atherosclerosis; 2015 Feb; 238(2):304-12. PubMed ID: 25545329
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the p.(Leu15Pro) and p.(Gly20Arg) sequence changes in the signal sequence of LDL receptor.
Pavloušková J; Réblová K; Tichý L; Freiberger T; Fajkusová L
Atherosclerosis; 2016 Jul; 250():9-14. PubMed ID: 27175606
[TBL] [Abstract][Full Text] [Related]
14. Two novel D151Y and M391T LDLR mutations causing LDLR transport defects in Thai patients with familial hypercholesterolemia.
Jeenduang N; Ruangpracha A; Promptmas C; Pongrapeeporn KU; Porntadavity S
Clin Chim Acta; 2010 Nov; 411(21-22):1656-61. PubMed ID: 20599862
[TBL] [Abstract][Full Text] [Related]
15. A chimeric LDL receptor containing the cytoplasmic domain of the transferrin receptor is degraded by PCSK9.
Holla ØL; Strøm TB; Cameron J; Berge KE; Leren TP
Mol Genet Metab; 2010 Feb; 99(2):149-56. PubMed ID: 19828345
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.
Maxwell KN; Fisher EA; Breslow JL
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2069-74. PubMed ID: 15677715
[TBL] [Abstract][Full Text] [Related]
17. Interaction between the ligand-binding domain of the LDL receptor and the C-terminal domain of PCSK9 is required for PCSK9 to remain bound to the LDL receptor during endosomal acidification.
Tveten K; Holla ØL; Cameron J; Strøm TB; Berge KE; Laerdahl JK; Leren TP
Hum Mol Genet; 2012 Mar; 21(6):1402-9. PubMed ID: 22156580
[TBL] [Abstract][Full Text] [Related]
18. Intracellular fate of LDL receptor family members depends on the cooperation between their ligand-binding and EGF domains.
Van Hoof D; Rodenburg KW; Van der Horst DJ
J Cell Sci; 2005 Mar; 118(Pt 6):1309-20. PubMed ID: 15741231
[TBL] [Abstract][Full Text] [Related]
19. Recognition of the carboxyl-terminal signal for GPI modification requires translocation of its hydrophobic domain across the ER membrane.
Wang J; Maziarz K; Ratnam M
J Mol Biol; 1999 Mar; 286(5):1303-10. PubMed ID: 10064698
[TBL] [Abstract][Full Text] [Related]
20. Analysis of LDLR mRNA in patients with familial hypercholesterolemia revealed a novel mutation in intron 14, which activates a cryptic splice site.
Kulseth MA; Berge KE; Bogsrud MP; Leren TP
J Hum Genet; 2010 Oct; 55(10):676-80. PubMed ID: 20703241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
